By Bansari Mayur Kamdar and Shashwat Chauhan
(Reuters) -European shares fell on Monday as French bank Societe Generale's shares slumped after a keenly awaited strategic plan from its new CEO disappointed investors, while caution reigned ahead of a slew of central bank meetings this week.
The pan-European STOXX 600 dropped 1.1% after rising close to 1.6% last week.
Societe Generale plummeted 12.1% to more than two month lows after France's third-biggest bank said it expected little, if any, growth in annual sales over the coming years.
The euro zone banks index dipped 1.9%.
Dragging down the healthcare sector, Novo Nordisk shares lost 2.4% after a report showed that U.S. drug regulators had recently issued a report detailing quality control lapses at the group's Clayton, North Carolina plant.
Rising bond yields across the euro zone pushed rate-sensitive real estate stocks down 2.6% following hawkish remarks by European Central Bank policymakers after the central bank raised borrowing costs by 25 basis points last week. [GVD/EUR]
Slovak policymaker Peter Kazimir said the ECB's rate hike on Thursday might have been its last for now but policymakers would need until March to be sure and further rises could yet be ruled out.
In a busy week for central bank meetings, the Bank of England (BoE) is expected to hike rates for the 15th time on Thursday, while the Federal Reserve looks set to hold rates on Wednesday.
"While forward guidance is likely to be limited, we expect the (BoE's) Monetary Policy Committee to strike a dovish tone indicating that a peak in the Bank Rate is near if not already reached," said Kirstine Kundby-Nielsen, analyst at Danske Bank.
The Swedish crown sank to a record low against the euro on Monday, days before the Riksbank is expected to raise interest rates again.
Among other individual movers, Nordic Semiconductor ASA shed 9.9% after cutting its revenue guidance for the third quarter. Peer Fingerprint Cards eased 10.0%.
Lonza's chief executive, Pierre-Alain Ruffieux, will leave the Swiss company by mutual agreement at the end of the month. This sent the contract drug manufacturer's shares down 14.7% amid concerns about the group's medium-term profit prospects.
Mondi rose 3.3% after the British paper and packaging company said it has agreed to sell its largest plant in Russia to a unit of Moscow-based real estate developer Sezar Group.
(Reporting by Bansari Mayur Kamdar and Shashwat Chauhan in Bengaluru; editing by Varun H K, Savio D'Souza and Mark Heinrich)
